The U.S. Food and Drug Administration recently approved a blood test that the U.S. Army Medical Materiel Development Activity at Fort Detrick worked on with Abbott Point of Care, which can more ...
- The test to help evaluate mild traumatic brain injury (TBI), commonly known as concussion, produces a result within 15 minutes after a plasma sample is inserted and will run on Abbott's i-STAT™ ...
VANCOUVER, British Columbia, Nov. 23, 2021 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce the signing of a non-exclusive, ...
The test, run on Abbott (ABT)'s portable i-STAT ® Alinity ® instrument, uses whole blood to help evaluate patients with a suspected mild traumatic brain injury (mTBI), or concussion The test produces ...
The test measures glial fibrillary acidic protein and ubiquitin carboxyl-terminal hydrolase L1, biomarkers present in blood plasma at elevated concentrations after a brain injury. The Food and Drug ...
The i-STAT TBI blood test is transforming traumatic brain injury (TBI) assessment, especially for sports-related concussions. The test, developed by Abbott along with the U.S. Department of Defense, ...
New test will run on Abbott's Alinity® i laboratory instrument, complementing Abbott's rapid i-STAT TBI Plasma test, cleared by the FDA in 2021 Given the significant number of Alinity i instruments in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results